Gene therapy (Record no. 121323)

MARC details
000 -LEADER
fixed length control field 03788nam a2200337 a 4500
001 - CONTROL NUMBER
control field 00002259
003 - CONTROL NUMBER IDENTIFIER
control field WSP
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20201015165205.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr buu|||uu|||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 091123s1994 si a sb 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency WSPC
Language of cataloging eng
Transcribing agency
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789814354189
Qualifying information (ebook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9810216548
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9810216556
Qualifying information (pbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9789810216542
050 04 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC271.G45
Item number G46 1994
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99406
Edition number 22
245 00 - TITLE STATEMENT
Title Gene therapy
Medium [electronic resource] :
Remainder of title from laboratory to the clinic /
Statement of responsibility, etc. edited by Kam M. Hui.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Singapore ;
-- River Edge, N.J. :
Name of publisher, distributor, etc. World Scientific Pub. Co.,
Date of publication, distribution, etc. c1994.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (viii, 278 p.) :
Other physical details ill.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note ch. 1. An introduction to gene therapy and cancer / Y.H. Tan -- ch. 2. Clinical strategies and expectations for the molecular biotherapy of cancer / H.K.B. Silver and R.J. Klasa -- ch. 3. Tumor-directed cytokine gene therapy / C.S. Chiang ... [et al.] -- ch. 4. Therapeutic applications of antisense nuclei acids / T.M.C. Tan, E.C.B. Nadala Jr. and R.C.Y. Ting -- ch. 5. Molecular targeting of cancer: retroviral vector-mediated antisense nuclei acid therapy / V. Zhang ... [et al.] -- ch. 6. DC-chol liposomes as DNA carriers for gene therapy / A. Singhal and L. Huang -- ch. 7. Accell particle bombardment for gene transfer as a useful gene therapy technique / N.S. Yang ... [et al.] -- ch. 8. DNA-coated microprojectiles for gene delivery into live animals / D.C. Tang and S.A. Johnston -- ch. 9. Expression of "foreign" class I major histocompatibility complex (MHC) molecules on experimental tumors and the induction of active specific cancer immunotherapy / K.M. Hui -- ch. 10. Gene transfer to the central nervous system mediated by herpes simplex virus vectors / J.C. Glorioso ... [et al.] -- ch. 11. Adeno-associated virus-based vectors for human gene therapy / R.J. Samulski.
520 ## - SUMMARY, ETC.
Summary, etc. With advances in our understanding of the molecular biology of human diseases and the development of efficient gene transfer techniques, the treatment of such diseases as cancer and infectious disease using gene therapy has progressed from a distant prospect to a distinct possibility in a very short time. The development of gene transfer methods which are suitable for different forms of therapy has been a major topic of research over the past several years. A common goal of this research has been to achieve the efficient delivery of genes into cells. The successful implementation of gene transfer as a cure for diseases, however, will continue to require the translation of preclinical studies in gene therapy into effective clinical protocols. This volume outlines the latest developments in cancer treatment using various gene delivery systems, which include cytokine gene transfer, the delivery of anti-ras DNA by retroviral vector and the injection of allogeneic HLA DNA via liposomes. Several of these molecular approaches have recently been approved by the US FDA as human clinical trial protocols in order to assess their therapeutic efficiency and safety for cancer treatment. Further developments in recombinant DNA technology within this field should ultimately lead to dramatic improvements in the practice of medicine.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction Singapore :
Agency responsible for reproduction World Scientific Publishing Co.,
Date of reproduction 1994.
Note about reproduction System requirements: Adobe Acrobat Reader.
-- Mode of access: World Wide Web.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Gene therapy.
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hui, Kam M.
Fuller form of name (Kam Man)
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element World Scientific (Firm)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://www.worldscientific.com/worldscibooks/10.1142/2259#t=toc">https://www.worldscientific.com/worldscibooks/10.1142/2259#t=toc</a>
Public note Access to full text is restricted to subscribers.

No items available.